Risk-reducing salpingo-oophorectomy (RRSO) proves to be an efficacious strategy for mitigating BC and ovarian cancer risk in females harbouring BRCA1/2 germline pathogenic variants, particularly in those of a younger age group. Here, BRCA1 is linked to ovarian cancer.